Efficacy and safety of adjuvant immunoadsorption in pemphigus vulgaris and pemphigus foliaceus (IA-Pem Study): a multicentre randomised controlled trial
CONCLUSIONS: In this study, adjuvant IA did not show a shorter time to clinical remission but a corticosteroid-sparing effect. In patients with extensive PV/PF, post hoc analysis suggests that adjuvant IA may possibly lead to earlier remission, but potential adverse events must be carefully weighed against the expected benefits.PMID:38133541 | DOI:10.1093/bjd/ljad489 (Source: The British Journal of Dermatology)
Source: The British Journal of Dermatology - December 22, 2023 Category: Dermatology Authors: Nina van Beek R üdiger Eming Alexander Reuss Detlef Zillikens Mikl ós Sárdy Claudia G ünther Dimitra Kiritsi Sandrine Benoit Stefan Beissert Regine Gl äser Harald Gollnick Orsolya N Horv áth Christiane Pfeiffer Martin R öcken Franziska Schauer Step Source Type: research
Efficacy and safety of adjuvant immunoadsorption in pemphigus vulgaris and pemphigus foliaceus (IA-Pem Study): a multicentre randomised controlled trial
CONCLUSIONS: In this study, adjuvant IA did not show a shorter time to clinical remission but a corticosteroid-sparing effect. In patients with extensive PV/PF, post hoc analysis suggests that adjuvant IA may possibly lead to earlier remission, but potential adverse events must be carefully weighed against the expected benefits.PMID:38133541 | DOI:10.1093/bjd/ljad489 (Source: The British Journal of Dermatology)
Source: The British Journal of Dermatology - December 22, 2023 Category: Dermatology Authors: Nina van Beek R üdiger Eming Alexander Reuss Detlef Zillikens Mikl ós Sárdy Claudia G ünther Dimitra Kiritsi Sandrine Benoit Stefan Beissert Regine Gl äser Harald Gollnick Orsolya N Horv áth Christiane Pfeiffer Martin R öcken Franziska Schauer Step Source Type: research
Efficacy and safety of adjuvant immunoadsorption in pemphigus vulgaris and pemphigus foliaceus (IA-Pem Study): a multicentre randomised controlled trial
CONCLUSIONS: In this study, adjuvant IA did not show a shorter time to clinical remission but a corticosteroid-sparing effect. In patients with extensive PV/PF, post hoc analysis suggests that adjuvant IA may possibly lead to earlier remission, but potential adverse events must be carefully weighed against the expected benefits.PMID:38133541 | DOI:10.1093/bjd/ljad489 (Source: The British Journal of Dermatology)
Source: The British Journal of Dermatology - December 22, 2023 Category: Dermatology Authors: Nina van Beek R üdiger Eming Alexander Reuss Detlef Zillikens Mikl ós Sárdy Claudia G ünther Dimitra Kiritsi Sandrine Benoit Stefan Beissert Regine Gl äser Harald Gollnick Orsolya N Horv áth Christiane Pfeiffer Martin R öcken Franziska Schauer Step Source Type: research
Efficacy and safety of adjuvant immunoadsorption in pemphigus vulgaris and pemphigus foliaceus (IA-Pem Study): a multicentre randomised controlled trial
CONCLUSIONS: In this study, adjuvant IA did not show a shorter time to clinical remission but a corticosteroid-sparing effect. In patients with extensive PV/PF, post hoc analysis suggests that adjuvant IA may possibly lead to earlier remission, but potential adverse events must be carefully weighed against the expected benefits.PMID:38133541 | DOI:10.1093/bjd/ljad489 (Source: The British Journal of Dermatology)
Source: The British Journal of Dermatology - December 22, 2023 Category: Dermatology Authors: Nina van Beek R üdiger Eming Alexander Reuss Detlef Zillikens Mikl ós Sárdy Claudia G ünther Dimitra Kiritsi Sandrine Benoit Stefan Beissert Regine Gl äser Harald Gollnick Orsolya N Horv áth Christiane Pfeiffer Martin R öcken Franziska Schauer Step Source Type: research
Clinical and immunopathological characteristics of autoimmune blistering skin diseases
Acta Dermatovenerol Alp Pannonica Adriat. 2023 Dec;32(4):141-149.ABSTRACTAutoimmune blistering skin diseases (AIBDs) encompass several heterogeneous conditions clinically characterized by blisters and erosions on the skin and mucous membranes and are immunopathologically characterized by autoantibodies against structural proteins of the skin. Those proteins are responsible for the intercellular contact between epidermal keratinocytes and adhesion of the basal keratinocytes to the dermis. Therefore, AIBDs are divided into two main groups: intraepidermal (the pemphigus group) and subepidermal (the pemphigoid) groups. The dia...
Source: Acta Dermatovenerologica Alpina, Panonica, et Adriatica - December 21, 2023 Category: Dermatology Authors: Anita Gunari ć Dubravka Šimić Branka Marinovi ć Source Type: research
